Does TECLISTAMAB Cause Pulmonary oedema? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Pulmonary oedema have been filed in association with TECLISTAMAB (TECVAYLI). This represents 1.7% of all adverse event reports for TECLISTAMAB.
21
Reports of Pulmonary oedema with TECLISTAMAB
1.7%
of all TECLISTAMAB reports
19
Deaths
20
Hospitalizations
How Dangerous Is Pulmonary oedema From TECLISTAMAB?
Of the 21 reports, 19 (90.5%) resulted in death, 20 (95.2%) required hospitalization, and 14 (66.7%) were considered life-threatening.
Is Pulmonary oedema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECLISTAMAB. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does TECLISTAMAB Cause?
Cytokine release syndrome (257)
Pneumonia (101)
Plasma cell myeloma (100)
Immune effector cell-associated neurotoxicity syndrome (99)
Pyrexia (86)
Covid-19 (82)
Infection (58)
Drug ineffective (52)
Neutropenia (48)
Sepsis (48)
What Other Drugs Cause Pulmonary oedema?
ADALIMUMAB (1,196)
MACITENTAN (1,019)
SACUBITRIL\VALSARTAN (958)
DASATINIB (873)
TREPROSTINIL (866)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (783)
AMLODIPINE (774)
LENALIDOMIDE (706)
FUROSEMIDE (571)
IBRUTINIB (494)
Which TECLISTAMAB Alternatives Have Lower Pulmonary oedema Risk?
TECLISTAMAB vs TECLISTAMAB-CQYV
TECLISTAMAB vs TEDIZOLID
TECLISTAMAB vs TEDUGLUTIDE
TECLISTAMAB vs TEDUGLUTIDE\WATER
TECLISTAMAB vs TEGAFUR